Glucoraphanin becomes active after a plant enzyme or gut bacteria. The strongest signal is a modest low-density lipoprotein cholesterol drop with high-glucoraphanin broccoli. Glucose findings are mixed. Liver enzymes and stomach-bacteria markers improve; urinary pollutant-breakdown products rise. Gas and bloating are the inconvenience. Thyroid labs were unchanged. Without the plant enzyme, conversion is often low. Not a demonstrated lifespan extender. (Full Review)

Protocol

Standard practitioner form

30–60 mg glucoraphanin daily

Glucoraphanin-plus-myrosinase tablet (Avmacol-type), or 30–70 g chewed 3-day broccoli sprouts

Food-first alternative

400 g/week high-glucoraphanin broccoli

Mustard powder on cooked broccoli restores conversion when myrosinase was heat-killed

Time of day

Once in the morning

Eructation (belching) with sulfur odor is often less bothersome with breakfast than late evening

Time to effect

Lower Low-Density Lipoprotein Cholesterol

8–12 weeks

High-glucoraphanin broccoli feeding trials

Improved Liver Enzymes in Fatty Liver

2 months

Glucoraphanin sprout extract versus baseline

Reduced Helicobacter pylori Colonization Markers

8 weeks

Markers returned after stopping

Benefits

High: Lower Low-Density Lipoprotein Cholesterol

Medium: Improved Liver Enzymes in Fatty Liver; Reduced Helicobacter pylori Colonization Markers; Improved Memory Scores in At-Risk Older Adults

Low: Improved Glycemic Control; Increased Urinary Excretion of Air-Pollutant Conjugates; Prostate Biochemical and Transcriptomic Signals

Speculative: Healthspan via NRF2 Programs; Histone-Deacetylase and Epigenetic Effects; Induction of Airway Phase 2 Enzyme RNA

Contraindications

Known allergy to broccoli or other Brassica foods (absolute contraindication for food and extracts from that biomass)

Infants given home-sprouted seeds

Pregnancy or breastfeeding at extract or high-sprout doses rather than ordinary food amounts

Uncontrolled hypothyroidism with documented iodine deficiency when the form is large amounts of raw cruciferous vegetables rather than a standardized extract

Key Interactions

Antibiotics (amoxicillin, metronidazole, other broad-spectrum agents)

Narrow-index CYP substrates (warfarin, some immunosuppressants, some antipsychotics)

Acetaminophen

Thyroid hormone (levothyroxine) and iodine

Other NRF2 inducers (curcumin, bardoxolone-class agents, high-dose green-tea catechins)

Mustard, daikon, or myrosinase powders

N-acetylcysteine and glutathione donors

Proton-pump inhibitors (omeprazole, esomeprazole, acid-reducing medications)

Risk & Side Effects

High: Gastrointestinal Symptoms

Low: Thyroid and Goitrogen Concern

Speculative: Altered Xenobiotic-Enzyme Tone; NRF2 Duality in Established Cancer; Brassica-Food Allergy and Sprout Pathogens; Seizure in People with Prior Seizure Disorder

Monitoring

Marker	Target	Why
LDL-C	<100 mg/dL (<70 mg/dL if high cardiovascular risk)	Tracks the replicated broccoli feeding signal
HbA1c (glycated hemoglobin)	4.8–5.3%	Captures 2–3 month glucose exposure
Fasting glucose	75–90 mg/dL (4.2–5.0 mmol/L)	Matches trial glycemic endpoints
ALT (alanine aminotransferase)	<25–30 U/L	Fatty-liver extract trials used this enzyme
GGT (γ-glutamyl transpeptidase)	<20–30 U/L	Second liver enzyme that moved with glucoraphanin
TSH (thyroid-stimulating hormone)	0.5–2.5 mIU/L	Documents thyroid status before a Brassica concentrate

Cadence: Baseline before starting; 8–12 weeks; then every 6–12 months during continued use. After recent antibiotics, a later lab set is more informative than an immediate one for enzyme-free products.

Qualitative Assessment

Energy and post-meal glucose steadiness over 8–12 weeks
Gastrointestinal comfort (gas, bloating, sulfur taste) as a tolerability gate
Subjective training recovery if exercise is a stated goal
Absence of new cold intolerance, palpitations, or neck fullness that would prompt thyroid retesting

Glucoraphanin for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment